NORA GLEASON: Open Payments
NPI 1609588854 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 7 payments from 5 companies in 2025. Trend: 2023 $435 · 2024 $0 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $51 |
| Lilly USA, LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Verona Pharma, Inc. | 1 | $15 |
Products named: Wegovy, MOUNJARO, BREZTRI, The Cologuard Plus Collection Kit, Ohtuvayre, Ozempic.
Industry payments across MD — which companies pay providers there.
